Adjust Font Size:

Press Releases

Advanced Cell Technology To Present Today at 18th Annual BioPartnering Europe Conference

MARLBOROUGH, Mass.-- (BUSINESS WIRE)--Advanced Cell Technology ("ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that William M. Caldwell IV, ACT's Chairman and CEO, will present today at the 18th Annual BioPartnering Europe conference in London at 11:45 a.m. eastern time today. The conference will take place at the Queen Elizabeth II Conference Centre in London.

*About Advanced Cell Technology, Inc.*

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com.

*Forward-Looking Statements*

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will,” "believes,” "plans,” "anticipates,” "expects,” "estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-K for the year ended December 31, 2009. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

Contact:
Investors:
CEOcast, Inc. for Advanced Cell
Dan Schustack, 212-732-4300
or
Press:
Gotham Communications, LLC
Bill Douglass, 646-450-3615

Press Contact


Bill Douglas
646-450-3615

Download PDF


BioPartnering_Relesae_Oct._11_2010.pdf

To view PDF Files, you must have Acrobat Reader.

Download Adobe Acrobat